GLORIA

GEOMAR Library Ocean Research Information Access

Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
Filter
  • University of Toronto Libraries - UOTL  (1)
  • Zarychanski, Ryan  (1)
Materialart
Verlag/Herausgeber
  • University of Toronto Libraries - UOTL  (1)
Sprache
Erscheinungszeitraum
  • 1
    Online-Ressource
    Online-Ressource
    University of Toronto Libraries - UOTL ; 2008
    In:  Clinical & Investigative Medicine Vol. 31, No. 4 ( 2008-08-01), p. 26-
    In: Clinical & Investigative Medicine, University of Toronto Libraries - UOTL, Vol. 31, No. 4 ( 2008-08-01), p. 26-
    Kurzfassung: Objectives: To evaluate the impact of HES solutions on adverse renal outcomes and mortality in critically ill patients requiring acute volume resuscitation. Design: Systematic review and meta-analysis of randomized controlled trials. Data Sources: We searched electronic databases from 1950 to 2007 (MEDLINE, EMBASE, the Cochrane Central Registry of Controlled Trials, and the SCOPUS database). Conference proceedings and grey literature sources were also searched from 2002-2007. Review Methods: We included all randomised controlled trials of patients requiring acute volume resuscitation who received HES compared to an alternative resuscitation fluid. No restrictions were considered regarding language or publication type. Data were independently extracted in duplicate. Results:Of 2381 citations reviewed, we included 22 trials (n=1866) in the analysis. Patients receiving HES were more likely to receive renal replacement therapy [odds ratio [OR] 1.91 (95% confidence interval [CI] 1.22-2.99, I^210.5%)]. This was also true for patients with severe sepsis or septic shock [OR 1.82 (95% CI 1.27-2.62, I^20%)]. In high quality trials, multicentre trials, and in reports indicating adequate allocation concealment, there was a trend toward increased risk of death associated with HES. Other adverse events were not systematically evaluated and were poorly reported. Limitations: Considerable clinical and methodologic heterogeneity exists among these trials. Conclusions: The use of HES for volume resuscitation in critically ill patients is associated with increased use of renal replacement therapy and may result in increased mortality. We caution against the routine use of HES for volume resuscitation in critically ill patients.
    Materialart: Online-Ressource
    ISSN: 1488-2353
    Sprache: Unbekannt
    Verlag: University of Toronto Libraries - UOTL
    Publikationsdatum: 2008
    ZDB Id: 2067562-8
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie hier...